Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Debora E. Peretti"'
Autor:
Jelle R. Dalenberg, Debora E. Peretti, Lenny R. Marapin, A. M. Madelein van der Stouwe, Remco J. Renken, Marina A. J. Tijssen
Publikováno v:
Frontiers in Human Neuroscience, Vol 18 (2024)
IntroductionThe Next Move in Movement Disorders (NEMO) study is an initiative aimed at advancing our understanding and the classification of hyperkinetic movement disorders, including tremor, myoclonus, dystonia, and myoclonus-dystonia. The study has
Externí odkaz:
https://doaj.org/article/306fa909c28f437ea92716b1ccdcd61c
Autor:
Débora E. Peretti, Federica Ribaldi, Max Scheffler, Linjing Mu, Valerie Treyer, Anton F. Gietl, Christoph Hock, Giovanni B. Frisoni, Valentina Garibotto
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundThe ATN model represents a research framework used to describe in subjects the presence or absence of Alzheimer’s disease (AD) pathology through biomarkers. The aim of this study was to describe the prevalence of different ATN profiles us
Externí odkaz:
https://doaj.org/article/ffa89413a5fa4806bb1cafeefb615179
Autor:
Débora E. Peretti, David Vállez García, Remco J. Renken, Fransje E. Reesink, Janine Doorduin, Bauke M. de Jong, Peter P. De Deyn, Rudi A. J. O. Dierckx, Ronald Boellaard
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Background 2-Deoxy-2-[18F]fluoroglucose (FDG) PET is an important tool for the identification of Alzheimer’s disease (AD) patients through the characteristic neurodegeneration pattern that these patients present. Regional cerebral blood fl
Externí odkaz:
https://doaj.org/article/d4b00876c702480a971a3f0ab3312051
Autor:
Elze R. Timmers, Débora E. Peretti, Marenka Smit, Bauke M. de Jong, Rudi A. J. O. Dierckx, Anouk Kuiper, Tom J. de Koning, David Vállez García, Marina A. J. Tijssen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract GTP-cyclohydrolase deficiency in dopa-responsive dystonia (DRD) patients impairs the biosynthesis of dopamine, but also of serotonin. The high prevalence of non-motor symptoms suggests involvement of the serotonergic pathway. Our study aimed
Externí odkaz:
https://doaj.org/article/dd3b0bff2a6c4eb5a4997a0bcdc1eef6
Autor:
Débora E. Peretti, David Vállez García, Fransje E. Reesink, Janine Doorduin, Bauke M. de Jong, Peter P. De Deyn, Rudi A. J. O. Dierckx, Ronald Boellaard
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-9 (2019)
Abstract Background In clinical practice, visual assessment of glucose metabolism images is often used for the diagnosis of Alzheimer’s disease (AD) through 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) scans. However, v
Externí odkaz:
https://doaj.org/article/57cc84a565b24176a148fc4240b2731a
Autor:
Débora E. Peretti, Remco J. Renken, Fransje E. Reesink, Bauke M. de Jong, Peter P. De Deyn, Rudi A.J.O. Dierckx, Janine Doorduin, Ronald Boellaard, David Vállez García
Publikováno v:
NeuroImage: Clinical, Vol 30, Iss , Pp 102625- (2021)
Scaled subprofile model using principal component analysis (SSM/PCA) is a multivariate analysis technique used, mainly in [18F]-2-fluoro-2-deoxy-d-glucose (FDG) PET studies, for the generation of disease-specific metabolic patterns (DP) that may aid
Externí odkaz:
https://doaj.org/article/f3665d6a7049484da8916403a172f04b
Autor:
Débora E. Peretti, Fransje E. Reesink, Janine Doorduin, Bauke M. de Jong, Peter P. De Deyn, Rudi A. J. O. Dierckx, Ronald Boellaard, David Vállez García
Publikováno v:
Frontiers in Physics, Vol 7 (2019)
Background: This study explores different approaches to estimate the clearance rate of the reference tissue (k2′) parameter used for pharmacokinetic modeling, using the simplified reference tissue model 2 (SRMT2) and further explores the effect on
Externí odkaz:
https://doaj.org/article/00b33a88bd3e418590bc4274744b7372